Series A · Biotech
Dash Bio raises $30M Series A
Dash Bio raised $30 million in Series A financing announced in August.
Oak HC/FT, Freestyle Capital and Swift Ventures are among its backers. The company provides automated bioanalysis for drug testing.
Funding history
Series A · This round$30M